Skip to main content

JDRF is undergoing a transformation.
We are becoming Breakthrough T1D in October.

breakthrought1d logo

Our impact in 2022

A year of unprecedented change

Seun wearing a JDRF running vest standing outside in the sun

2022 in numbers


Raised for UK research projects


Support resources given to people with type 1 and healthcare professionals


People supported by our community events

Achievements against our mission goals

We’re in the second year of our bold three-year strategy and have made significant progress towards our vision of a world without type 1 diabetes. With our incredible supporters, we’ve been able to advance major breakthroughs in research, transformed access to life-changing technology and expanded our reach to support more people.

It’s this commitment from our funders that’s enabled us to make these significant leaps in 2022. By helping us push the boundaries in our understanding of type 1, together we’re paving the way for future cures that are closer than ever before.

Goal 1: Drive research to cure, treat and prevent type 1 diabetes

A JDRF UK type 1 diabetes researcher in the laboratory

We’re committed to increasing funding for world-class international type 1 diabetes research, with UK research teams at the forefront.

In April 2022 we launched the £50 million Type 1 Diabetes Grand Challenge, a ground-breaking partnership between JDRF, the Steve Morgan Foundation (SMF) and Diabetes UK which will accelerate research to find cures for type 1 over the next five years. This partnership brings together research team across the UK and will transform the lives of people with type 1 and lead the race towards cures. We are grateful to our long-term major donors, Steve and Sally Morgan, for the £50 million investment, the largest ever single philanthropic gift in the UK for type 1 diabetes research.

We also funded several exciting research projects:

  • We’re co-funding a new screening trial that could transform the way type 1 is identified and managed in its earliest stages. The Early Surveillance for Autoimmune diabetes project (ELSA) is the first of its kind in the UK to identify children aged 3-13 who are at high risk of developing type 1.
  • Teplizumab, an immunotherapy drug, can delay type 1 by up to three years was approved for use in the US. The drug tackles the root cause of the condition and has the potential to slow progression of type 1 in the long-term.
  • Under our leadership, the Connect Immune Research partnership is researching the common causes between autoimmune conditions. This will lead to an increase in the development of treatments which target multiple conditions. The initiative welcomed patient support charity British Thyroid Foundation as well as The Royal Free Charity, which supports the three hospitals in the Royal Free London NHS Foundation Trust.

Goal 2: Accelerate access to type 1 technologies and medicines

A woman who is looking at the continuous glucose monitor on her arm

We’re influencing greater access to type 1 technology and treatments on the NHS. We’re also empowering people with type 1 to become involved in research and regulatory approval.

Goal 3: Support people living with type 1

Two men sitting together reading a JDRF information leaflet

We’re a trusted source of information and provided expert, specialist information and advice through our website and toolkits.

  • We worked collaboratively with Diabetes UK, NHS England and people with lived experience, to produce The Six Principles of Good Peer Support for People Living with Type 1 Diabetes. Having someone who understands what you’re going through when living with type 1 can make a huge difference. Support from other people experiencing type 1, called peer support, can help people learn to manage their condition.
  • Living with diabetes can be an overwhelming experience for children and young people. As many as 6 in 10 experience what is known as severe diabetes distress, where their mental health is affected. If untreated, it can lead to depression and even posttraumatic stress disorder. We teamed up with DigiBete to provide children, young people and their families with the information and support they need to live well with type 1 diabetes.

Shared stories

Thank you for making it all possible

Thanks to our supporters, we made extraordinary progress in 2022 towards our three goals. We’re now in an exciting time of scientific advances that we couldn’t have imagined ten years ago – and the pace of change means we could be on the edge of the next big breakthrough.

Our Accelerator Programme Members

  • Dominic Christian and Kate Birch
  • Lincoln Benet
  • The Claringbull Family
  • Niall Curran and Sue Reid
  • Rosemary, Gordon and Cameron Fuller
  • The Haywood Family
  • Patrick and Jane Kennedy
  • Wilson Leech
  • The Manktelow Family
  • The Rt Hon Theresa May MP
  • The Pardoe Family
  • The Sethia Family
  • The Wilkinson Family
  • The Zhao Family


  • Abbott Diabetes Care UK
  • Dexcom UK Distribution Ltd
  • Insulet International Ltd
  • Roche Diabetes Care UK
  • Lilly UK
  • Novo Nordisk Ltd
  • Sanofi UK
  • Air Liquide Healthcare Ltd
  • Medtronic Ltd
  • Medtrum Ltd
  • Menarini Diagnostics Ltd
  • Dextro Energy GmbH
  • The Syncona Foundation
  • Ford Motor Company Ltd
  • Peter Cooper Motor Group
  • Hoban Waste Management
  • Nelsons


  • Coldstones Charitable Trust
  • The Elizabeth and Prince Zaiger Trust
  • Hans and Julia Rausing Trust
  • Hummingbird Charitable Trust
  • Nimar Charitable Trust
  • Peter Harrison Foundation
  • PF Charitable Trust
  • Robert Barr’s Charitable Trust
  • Robert Luff Foundation Limited

2022 in numbers


Families supported with newly-diagnosed resources


KIDSACs distributed to support newly-diagnosed children


Visits to our website

How you can help

Read more


Your donations make a real difference to the lives of everyone living with type 1 diabetes and the people who care for them.

Read more


By joining one of our fundraising events or planning your own, you’ll be helping fund type 1 research that’s making headway.

Read more


Buy JDRF merchandise including T-shirts, cycling jerseys and pin badges and help support type 1 research.

Read more


Build your skills, meet new people and have fun, all while making a real difference.

Join our social communities